1. Home
  2. VRXA vs QUIK Comparison

VRXA vs QUIK Comparison

Compare VRXA & QUIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veraxa Biotech AG Ordinary Shares

VRXA

Veraxa Biotech AG Ordinary Shares

N/A

Current Price

$1.06

Market Cap

161.2M

Sector

Health Care

ML Signal

N/A

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

N/A

Current Price

$9.77

Market Cap

186.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
VRXA
QUIK
Founded
2021
1988
Country
Germany
United States
Employees
N/A
51
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
161.2M
186.1M
IPO Year
2025
1997

Fundamental Metrics

Financial Performance
Metric
VRXA
QUIK
Price
$1.06
$9.77
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $17.33
AVG Volume (30 Days)
142.5K
★ 167.9K
Earning Date
N/A
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $20,112,000.00
Revenue This Year
N/A
$73.22
Revenue Next Year
N/A
$18.40
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.90
$5.41
52 Week High
$4.50
$24.33

Technical Indicators

Market Signals
Indicator
VRXA
QUIK
Relative Strength Index (RSI) 45.85 55.10
Support Level $0.92 $8.72
Resistance Level $1.29 $10.14
Average True Range (ATR) 0.10 0.81
MACD 0.01 0.22
Stochastic Oscillator 32.57 78.26

Price Performance

Historical Comparison
VRXA
QUIK

About VRXA Veraxa Biotech AG Ordinary Shares

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

Share on Social Networks: